128 related articles for article (PubMed ID: 33394961)
1. NATURAL COURSE OF VITREOMACULAR TRACTION IN EYES WITH DIABETIC RETINOPATHY AND FACTORS ASSOCIATED WITH SPONTANEOUS RELEASE.
Garip R; Çınar AK; Çınar AC; Gürlü V
Retina; 2021 Aug; 41(8):1668-1674. PubMed ID: 33394961
[TBL] [Abstract][Full Text] [Related]
2. Vitreomacular traction in diabetic retinopathy.
Hsieh YT; Yang CM
Jpn J Ophthalmol; 2024 Jan; 68(1):12-18. PubMed ID: 38001367
[TBL] [Abstract][Full Text] [Related]
3. Long-term evaluation of vitreomacular traction disorder in spectral-domain optical coherence tomography.
Odrobina D; Michalewska Z; Michalewski J; Dzięgielewski K; Nawrocki J
Retina; 2011 Feb; 31(2):324-31. PubMed ID: 21416651
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous resolution of vitreomacular traction demonstrated by spectral-domain optical coherence tomography.
Theodossiadis GP; Grigoropoulos VG; Theodoropoulou S; Datseris I; Theodossiadis PG
Am J Ophthalmol; 2014 Apr; 157(4):842-851.e1. PubMed ID: 24445034
[TBL] [Abstract][Full Text] [Related]
5. A novel spectral-domain optical coherence tomography model to estimate changes in vitreomacular traction syndrome.
Codenotti M; Iuliano L; Fogliato G; Querques G; Bandello F
Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1729-35. PubMed ID: 24764038
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors associated with the course of vitreomacular traction in eyes with age-related macular degeneration.
Garip R; Çınar AK; Çınar AC; Sakallıoğlu AK; Güçlü H; Gürlü V
Photodiagnosis Photodyn Ther; 2022 Dec; 40():103025. PubMed ID: 35870775
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography.
Koizumi H; Spaide RF; Fisher YL; Freund KB; Klancnik JM; Yannuzzi LA
Am J Ophthalmol; 2008 Mar; 145(3):509-517. PubMed ID: 18191099
[TBL] [Abstract][Full Text] [Related]
8. Real-life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study.
Chatziralli I; Theodossiadis G; Parikakis E; Datseris I; Theodossiadis P
Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):223-33. PubMed ID: 25940555
[TBL] [Abstract][Full Text] [Related]
9. Clinical Course of Vitreomacular Traction Managed Initially by Observation.
Tzu JH; John VJ; Flynn HW; Smiddy WE; Jackson JR; Isernhagen BA; Carver A; Leonard R; Tabandeh H; Boyer DS; Berrocal MH; Suzuki M; Freund KB; Gross JG
Ophthalmic Surg Lasers Imaging Retina; 2015 May; 46(5):571-6. PubMed ID: 26057761
[TBL] [Abstract][Full Text] [Related]
10. THE EFFECT OF ELECTIVE CATARACT EXTRACTION BY PHACOEMULSIFICATION IN EYES WITH VITREOMACULAR TRACTION SYNDROME.
Mantopoulos D; Prenner JL; Patel VK; Roth DB; Shah SP; Tsavaris O; Fine HF; Wheatley HM
Retina; 2021 Jan; 41(1):75-81. PubMed ID: 32106158
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic Vitreolysis for Vitreomacular Traction in Diabetic Retinopathy.
Rizzo S; Bacherini D
Dev Ophthalmol; 2017; 60():160-164. PubMed ID: 28427074
[TBL] [Abstract][Full Text] [Related]
12. Anatomical configurations of vitreomacular traction syndrome: influence on clinical course and surgical outcomes.
Lee EK; Lee SY; Lee JY; Heo JW; Yu HG; Chung H
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1631-1639. PubMed ID: 31104140
[TBL] [Abstract][Full Text] [Related]
13. Natural course of vitreomacular traction syndrome observed by spectral-domain optical coherence tomography.
Zhang Z; Dong F; Zhao C; Dai R; Yu W; Zheng L; He F; Yang Z
Can J Ophthalmol; 2015 Apr; 50(2):172-9. PubMed ID: 25863860
[TBL] [Abstract][Full Text] [Related]
14. Ocriplasmin treatment for vitreomacular traction in real life: can the indication spectrum be expanded?
Manousaridis K; Peter-Reichart S; Mennel S
Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1907-1916. PubMed ID: 28681138
[TBL] [Abstract][Full Text] [Related]
15. Short-term changes in posterior vitreous cortex following intravitreal ocriplasmin for symptomatic vitreomacular traction syndrome: a prospective study.
Cacciamani A; Gattegna R; Pileri M; Di Nicola M; Bardanzellu S; Facciolo G; Cosimi P; Govetto A; Scarinci F
Int Ophthalmol; 2020 Jan; 40(1):185-193. PubMed ID: 31565760
[TBL] [Abstract][Full Text] [Related]
16. Variability in Presentation of Bilateral Vitreomacular Traction.
Rodman J; Prete B; Steen J; Shechtman D
Optom Vis Sci; 2016 Mar; 93(3):310-7. PubMed ID: 26760576
[TBL] [Abstract][Full Text] [Related]
17. INTRAVITREAL SULFUR HEXAFLUORIDE INJECTION FOR THE TREATMENT OF VITREOMACULAR TRACTION SYNDROME.
Day S; Martinez JA; Nixon PA; Levitan M; Dooner JW; Wong RW; Harper CA
Retina; 2016 Apr; 36(4):733-7. PubMed ID: 26383712
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the horizontal diameter to a modeled area of traction in eyes with vitreomacular traction: is the diameter close enough to the truth?
Paul C; Krug P; Müller HH; Wachtlin J; Mennel S; Müller S; Schmitz-Valckenberg S; Bertelmann T; Schumann RG
Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):1817-1822. PubMed ID: 29955972
[TBL] [Abstract][Full Text] [Related]
19. Rate and timing of spontaneous resolution in a vitreomacular traction group: should the role of watchful waiting be re-evaluated as an alternative to ocriplasmin therapy?
Dimopoulos S; Bartz-Schmidt KU; Gelisken F; Januschowski K; Ziemssen F
Br J Ophthalmol; 2015 Mar; 99(3):350-3. PubMed ID: 25342274
[TBL] [Abstract][Full Text] [Related]
20. Subfoveal Lucency after Treatment of Vitreomacular Traction without Macular Hole in the Phase 3 Trials of Ocriplasmin Vitreolysis.
Thomas AS; Folgar FA; Jaffe GJ; Toth CA; Mahmoud TH
Ophthalmol Retina; 2019 Jan; 3(1):42-52. PubMed ID: 30929816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
